Skip to main content
# Title Research Year
101 Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects 2020
102 Clinical and microbial characterization of toxigenic Clostridium difficile
isolated from antibiotic associated diarrhea in Egypt
2020
103 Downregulation of B regulatory cells and upregulation of T helper
1 cells in children with Gaucher disease undergoing enzyme
replacement therapy
2020
104 IP-10 Levels in Patients Infected with HBV Predicts The Response to Treatment with Entecavir 2020
105 Circulation of hepatitis E virus (HEV) and/or HEV-like agent in non-mixed dairy farms could represent a potential source of infection for Egyptian people 2020
106 Intricate Relationship Between Adaptive and Innate Immune System in Allergic Contact Dermatitis 2020
107 Enhancement of the Molecular and Serological Assessment of Hepatitis E Virus in Milk Samples
2020
108 Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and
Prevention Strategies
2020
109 Replication of Hepatitis E Virus (HEV) in Primary Human-Derived Monocytes and Macrophages In Vitro 2020
110 Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus
2020